Corbus Pharmaceuticals (CRBP) has been on a downward spiral lately with significant selling pressure. After declining 22.9% ...

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP shed 4.74% to $6.03 Wednesday, on what proved to be an all-around ...

Shares of CRBP stock opened at $6.96 on Monday. The firm’s 50-day simple moving average is $9.32 and its 200-day simple moving average is $18.10. Corbus Pharmaceuticals has a 1-year low of $6.38 ...

CRBP opened at $6.96 on Monday. Corbus Pharmaceuticals has a one year low of $6.38 and a one year high of $61.90. The stock’s fifty day moving average is $9.32 and its 200-day moving average is ...

Corbus Pharmaceuticals (CRBP) could be a solid choice for investors ... which is one of the most powerful forces impacting stock prices. The sole determinant of the Zacks rating is a company's ...

Oppenheimer analyst Jeff Jones reiterated a Buy rating on Corbus Pharmaceuticals (CRBP – Research Report) today and set a price target of ...

RBC Capital analyst Brian Abrahams maintained a Buy rating on Corbus Pharmaceuticals (CRBP – Research Report) yesterday and set a price target ...

Corbus Pharmaceuticals Holdings Inc. (CRBP) on Tuesday reported a loss of $9.5 million in its fourth quarter. The Norwood, Massachusetts-based company said it had a loss of 78 cents per share. The ...

The stock's fall snapped a two-day winning streak.